Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert G. Savage currently holds 199,869 shares of EPICEPT CORP (EPCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert G. Savage has been a net seller of EPCT stock. They have purchased $0 and sold $2.2M worth of shares.
Robert G. Savage's most recent insider trade was on May 14, 2019, when they sold 100,000 shares at $0.67 per share.
Robert G. Savage serves as Executive at EPICEPT CORP (EPCT). They have executed 39 insider transactions totaling $2.2M over their tenure at the company.
Robert G. Savage holds the position of Executive at EPICEPT CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Robert G. Savage has shown a selling trading pattern, with $0 in total purchases and $2.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert G. Savage was on May 20, 2015, when they sold $401.7K worth of MDCO shares. This transaction involved 15,000 shares at $26.78 per share.
Robert G. Savage currently owns 199,869 shares of EPICEPT CORP (EPCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert G. Savage's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert G. Savage has 39 Form 4 filings on record as an insider at EPICEPT CORP.
Set alerts for Robert G. Savage and 40,000+ other insiders.